 | Up a level |
Group by: Item Type | No Grouping
Number of items: 1.
Morgensztern, Daniel, Besse, Benjamin, Greillier, Laurent 
ORCID: 0000-0002-5807-9503, Santana-Davila, Rafael, Ready, Neal, Hann, Christine L., Glisson, Bonnie S., Farago, Anna F., Dowlati, Afshin, Rudin, Charles M., Le Moulec, Sylvestre, Lally, Satwant, Yalamanchili, Sreeni, Wolf, Juergen, Govindan, Ramaswamy and Carbone, David P.
(2019).
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.
Clin. Cancer Res., 25 (23).
S. 6958 - 6967.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265